Teva Pharmaceutical Industries Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $5.37B | $3.30B |
| FY2025 | — | $7.91B | $3.56B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $5.37B | $3.30B |
| FY2025 | — | $7.91B | $3.56B |